TX-AG v. Pfizer

Pfizer, Inc., Tris Pharma, Inc. and Tris CEO Ketan Mehta allegedly defrauded the Texas Medicaid program by providing adulterated pharmaceutical drugs to Texas children in violation of the Texas Medicaid Fraud Prevention Act, now known as the Texas Health Care Program Fraud Prevention Act. Pfizer allegedly misrepresented to the Medicaid program that Quillivant was in compliance with federal and state law, and concealed from Medicaid decision-makers the fact that Quillivant was an adulterated drug. As a result of these misrepresentations and concealments, Pfizer and Tris allegedly obtained the benefit of taxpayer-funded Medicaid reimbursement for Quillivant.

Summary generated from official Texas Attorney General press release